Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.

Tosi A, Dalla Santa S, Cappuzzello E, Marotta C, Walerich D, Del Sal G, Zanovello P, Sommaggio R, Rosato A.

Oncoimmunology. 2017 Apr 5;6(8):e1313371. doi: 10.1080/2162402X.2017.1313371. eCollection 2017.

PMID:
28919988
2.

The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.

Vange P, Bruland T, Doseth B, Fossmark R, Sousa MML, Beisvag V, Sørdal Ø, Qvigstad G, Waldum HL, Sandvik AK, Bakke I.

PLoS One. 2017 Sep 13;12(9):e0184514. doi: 10.1371/journal.pone.0184514. eCollection 2017.

3.

miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.

Zheng L, Chen Y, Ye L, Jiao W, Song H, Mei H, Li D, Yang F, Li H, Huang K, Tong Q.

Sci Rep. 2017 Aug 21;7(1):8967. doi: 10.1038/s41598-017-09271-5.

4.

Voltage-gated calcium channels: Novel targets for cancer therapy.

Phan NN, Wang CY, Chen CF, Sun Z, Lai MD, Lin YC.

Oncol Lett. 2017 Aug;14(2):2059-2074. doi: 10.3892/ol.2017.6457. Epub 2017 Jun 22.

5.

Thrombospondin-4 mediates TGF-β-induced angiogenesis.

Muppala S, Xiao R, Krukovets I, Verbovetsky D, Yendamuri R, Habib N, Raman P, Plow E, Stenina-Adognravi O.

Oncogene. 2017 Sep 7;36(36):5189-5198. doi: 10.1038/onc.2017.140. Epub 2017 May 8.

PMID:
28481870
6.

Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.

Xie S, Shen C, Tan M, Li M, Song X, Wang C.

Oncotarget. 2017 Apr 18;8(16):27216-27239. doi: 10.18632/oncotarget.16111.

7.

Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer.

Deivendran S, Marzook H, Santhoshkumar TR, Kumar R, Pillai MR.

Sci Rep. 2017 Apr 10;7:44225. doi: 10.1038/srep44225.

8.

Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.

Wang CY, Shahi P, Huang JT, Phan NN, Sun Z, Lin YC, Lai MD, Werb Z.

Mol Clin Oncol. 2017 Jan;6(1):7-18. doi: 10.3892/mco.2016.1094. Epub 2016 Nov 25.

9.

SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.

Mukherjee N, Cardenas E, Bedolla R, Ghosh R.

Oncotarget. 2017 Feb 28;8(9):15114-15125. doi: 10.18632/oncotarget.14750.

10.

Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.

Chao T, Zhou X, Cao B, Liao P, Liu H, Chen Y, Park HW, Zeng SX, Lu H.

Nat Commun. 2016 Dec 23;7:13755. doi: 10.1038/ncomms13755.

11.

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.

Li Y, Huang J, Sun J, Xiang S, Yang D, Ying X, Lu M, Li H, Ren G.

Oncotarget. 2017 Jan 17;8(3):4501-4519. doi: 10.18632/oncotarget.13885.

12.

miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.

Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.

J Exp Clin Cancer Res. 2016 Nov 11;35(1):176.

13.

PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.

Cai XP, Chen LD, Song HB, Zhang CX, Yuan ZW, Xiang ZX.

Am J Transl Res. 2016 Oct 15;8(10):4172-4183. eCollection 2016.

14.

Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.

Duan F, Jia D, Zhao J, Wu W, Min L, Song S, Wu H, Wang L, Wang H, Ruan Y, Gu J.

Oncotarget. 2016 Jun 21;7(25):38427-39. doi: 10.18632/oncotarget.9538.

15.

Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer.

Peng P, Wu W, Zhao J, Song S, Wang X, Jia D, Shao M, Zhang M, Li L, Wang L, Duan F, Zhao R, Yang C, Wu H, Zhang J, Shen Z, Ruan Y, Gu J.

Sci Rep. 2016 Jul 12;6:29604. doi: 10.1038/srep29604.

16.

Screening Driving Transcription Factors in the Processing of Gastric Cancer.

Xu G, Li K, Zhang N, Zhu B, Feng G.

Gastroenterol Res Pract. 2016;2016:8431480. doi: 10.1155/2016/8431480. Epub 2016 Jun 15.

17.

Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.

Zhao N, Zhang C, Zhao Y, Bai B, An J, Zhang H, Wu JB, Shi C.

Oncotarget. 2016 Aug 30;7(35):57277-57289. doi: 10.18632/oncotarget.10031.

18.

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.

Guo L, Zhang S, Zhang B, Chen W, Li X, Zhang W, Zhou C, Zhang J, Ren N, Ye Q.

Cell Biol Toxicol. 2016 Aug;32(4):263-74. doi: 10.1007/s10565-016-9327-z. Epub 2016 May 30.

19.

Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.

Shen JX, Liu J, Li GW, Huang YT, Wu HT.

Oncotarget. 2016 May 3;7(18):25340-9. doi: 10.18632/oncotarget.8294.

20.

PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.

Kwon CH, Park HJ, Choi YR, Kim A, Kim HW, Choi JH, Hwang CS, Lee SJ, Choi CI, Jeon TY, Kim DH, Kim GH, Park do Y.

Oncotarget. 2016 Apr 19;7(16):21454-68. doi: 10.18632/oncotarget.7411.

Supplemental Content

Support Center